Oneness Biotech Co., Ltd. (TPEX:4743)

Oneness Biotech Revenue

Oneness Biotech had revenue of 39.91M TWD in the quarter ending June 30, 2026, with 49.75% growth. This brings the company's total for the last twelve months to 153.78M, up 36.61% year-over-year. In the year 2025, Oneness Biotech had annual revenue of 129.12M with 9.49% growth. That makes Oneness Biotech the 40,128th largest company in the world by revenue and 2,077th in Taiwan.

• Revenue (ttm): 153.78M
• Revenue Growth: +36.61%
• P/S Ratio: 150.13
• Revenue / Employee: 3.58M
• Employees: 43
• Market Cap: 23.09B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Research and development of new medicine 82.70M 64.0%
• Organic and Health-related Products 46.42M 36.0%

Fiscal year ended Dec 31, 2025 See the full Oneness Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	129.12M	11.20M	9.49%
Dec 31, 2024	117.93M	31.14M	35.89%
Dec 31, 2023	86.78M	-978.77M	-91.86%
Dec 31, 2022	1.07B	999.79M	1,520.24%
Dec 31, 2021	65.77M	24.16M	58.07%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 15, 2026

Data Sources Report a data error